BACKGROUND: fibroblast growth factor receptor (FGFR) -related craniosynostosis syndromes are caused by many different mutations within FGFR-1, 2, 3, and certain FGFR mutations are associated with more than one clinical syndrome. These syndromes share coronal craniosynostosis and characteristic facial skeletal features, although Apert syndrome (AS) is characterized by a more dysmorphic facial skeleton relative to Crouzon (CS), Muenke (MS), or Pfeiffer syndromes. METHODS: Here we perform a detailed three-dimensional evaluation of facial skeletal shape in a retrospective sample of cases clinically and/or genetically diagnosed as AS, CS, MS, and Pfeiffer syndrome to quantify variation in facial dysmorphology, precisely identify specific facial features pertaining to these four syndromes, and further elucidate what knowledge of the causative FGFR mutation brings to our understanding of these syndromes. RESULTS: Our results confirm a strong correspondence between genotype and facial phenotype for AS and MS with severity of facial dysmorphology diminishing from Apert FGFR2(S252W) to Apert FGFR2(P253R) to MS. We show that AS facial shape variation is increased relative to CS, although CS has been shown to be caused by numerous distinct mutations within FGFRs and reduced dosage in ERF. CONCLUSION: Our quantitative analysis of facial phenotypes demonstrate subtle variation within and among craniosynostosis syndromes that might, with further research, provide information about the impact of the mutation on facial skeletal and nonskeletal development. We suggest that precise studies of the phenotypic consequences of genetic mutations at many levels of analysis should accompany next-generation genetic research and that these approaches should proceed cooperatively.
BACKGROUND: fibroblast growth factor receptor (FGFR) -related craniosynostosis syndromes are caused by many different mutations within FGFR-1, 2, 3, and certain FGFR mutations are associated with more than one clinical syndrome. These syndromes share coronal craniosynostosis and characteristic facial skeletal features, although Apert syndrome (AS) is characterized by a more dysmorphic facial skeleton relative to Crouzon (CS), Muenke (MS), or Pfeiffer syndromes. METHODS: Here we perform a detailed three-dimensional evaluation of facial skeletal shape in a retrospective sample of cases clinically and/or genetically diagnosed as AS, CS, MS, and Pfeiffer syndrome to quantify variation in facial dysmorphology, precisely identify specific facial features pertaining to these four syndromes, and further elucidate what knowledge of the causative FGFR mutation brings to our understanding of these syndromes. RESULTS: Our results confirm a strong correspondence between genotype and facial phenotype for AS and MS with severity of facial dysmorphology diminishing from Apert FGFR2(S252W) to Apert FGFR2(P253R) to MS. We show that AS facial shape variation is increased relative to CS, although CS has been shown to be caused by numerous distinct mutations within FGFRs and reduced dosage in ERF. CONCLUSION: Our quantitative analysis of facial phenotypes demonstrate subtle variation within and among craniosynostosis syndromes that might, with further research, provide information about the impact of the mutation on facial skeletal and nonskeletal development. We suggest that precise studies of the phenotypic consequences of genetic mutations at many levels of analysis should accompany next-generation genetic research and that these approaches should proceed cooperatively.
Authors: S F Slaney; M Oldridge; J A Hurst; G M Moriss-Kay; C M Hall; M D Poole; A O Wilkie Journal: Am J Hum Genet Date: 1996-05 Impact factor: 11.025
Authors: Yann Heuzé; Neus Martínez-Abadías; Jennifer M Stella; Craig W Senders; Simeon A Boyadjiev; Lun-Jou Lo; Joan T Richtsmeier Journal: J Exp Zool B Mol Dev Evol Date: 2012-03 Impact factor: 2.656
Authors: M M Cohen; S Kreiborg; E J Lammer; J F Cordero; P Mastroiacovo; J D Erickson; P Roeper; M L Martínez-Frías Journal: Am J Med Genet Date: 1992-03-01
Authors: Vikram P Sharma; Aimée L Fenwick; Mia S Brockop; Simon J McGowan; Jacqueline A C Goos; A Jeannette M Hoogeboom; Angela F Brady; Nu Owase Jeelani; Sally Ann Lynch; John B Mulliken; Dylan J Murray; Julie M Phipps; Elizabeth Sweeney; Susan E Tomkins; Louise C Wilson; Sophia Bennett; Richard J Cornall; John Broxholme; Alexander Kanapin; David Johnson; Steven A Wall; Peter J van der Spek; Irene M J Mathijssen; Robert E Maxson; Stephen R F Twigg; Andrew O M Wilkie Journal: Nat Genet Date: 2013-01-27 Impact factor: 38.330
Authors: Kate M Lesciotto; Yann Heuzé; Ethylin Wang Jabs; Joseph M Bernstein; Joan T Richtsmeier Journal: Plast Reconstr Surg Date: 2018-01 Impact factor: 4.730
Authors: Greg Holmes; Courtney O'Rourke; Susan M Motch Perrine; Na Lu; Harm van Bakel; Joan T Richtsmeier; Ethylin Wang Jabs Journal: Development Date: 2018-10-05 Impact factor: 6.868
Authors: Benedikt Hallgrimsson; Christopher J Percival; Rebecca Green; Nathan M Young; Washington Mio; Ralph Marcucio Journal: Curr Top Dev Biol Date: 2015-10-27 Impact factor: 4.897
Authors: Susan M Motch Perrine; Theodore M Cole; Neus Martínez-Abadías; Kristina Aldridge; Ethylin Wang Jabs; Joan T Richtsmeier Journal: BMC Dev Biol Date: 2014-02-28 Impact factor: 1.978